LIPOLYTIC PEPTIDES

Abstract: lipolytic peptides having a length from 5 to 9 amino acids and corresponding to seq id no: 54 or a salt thereof, wherein: xrepresents w or n; xrepresents p, n, a basic amino acid or a hydrophobic amino acid; xand xare the same or different and represent a, v, l or i; xrepresents f or p; subindexes “a”, “b”, “c”, “d”, “e”, “f” and “g” are integer numbers independently selected from 0 and 1, provided that two, three, four, five or six of the subindexes “a”, “b”, “c”, “d”, “e”, “f” and “g” represent 1 and the remaining represent “0”. peptides of sequence seq id no: 39-46 or any salt thereof. the peptides show improved lipolytic activity when compared with other lipolytic agents, such as caffeine or hexa-39.

Inventor(s): DAVID MARTINEZ SELVA, RAFAEL SIMÓ CANONGE

CPC Classification: C07K7/06 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250154197